Search Results 1851-1860 of 4061 for Solid

1. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   ... Solid Tumors (RECIST) criteria; Ability to understand and the willingness to sign a written informed consent document; Histological or cytologically confirmed ...

2. A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy (MOUNTAINSIDE) - Mayo Clinic

   ... cancer (e.g., basal cell or squamous cell carcinoma). - Participant has a solid organ transplant and/or is currently receiving treatment with therapy for ...

3. Clinical trials - Oncology (Medical)

   A Pilot Study to Evaluate the Molecular and Biological Phenotype of Peripheral Immune Cells in Solid Tumor Patients. Rochester, Minn. The purpose of this ...

4. Clinical trials - Oncology (Medical)

   ... solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and ...

5. Diverse ways regenerative medicine is advancing health care

   We hope that regenerative sciences will discover and perfect ways to expand this treatment approach to solid cancers, as well," says Dr. Terzic ...

6. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Other completely resected stage 1 solid tumor with low risk for recurrence. Treatment with any prior gene therapy product. Subjects who have received ...

7. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.

8. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria is required except for subjects with bone only disease. All prior ...

9. Clinical trials - Oncology (Medical)

   ... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...

10. Oncology (Medical) - Clinical trials

    ... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined ...